drugset / Trial / NCT05118685

Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis

NCT05118685

Phase 1 Unknown 100 enrolled Fayoum University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to compare the efficacy, acceptability, and safety of vaginal estrogen cream and platelet-rich plasma in pt. complaining of atrophic vaginitis.

Timeline

Start
2021-11-13
Primary completion
2023-08
Completion
2023-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 5 ml Other
Comparator conjugated estrogens Other / unclassified 0.625 mg Other